AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glibmor M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Morgen Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glibmor M 2mg/500mg Tablet ER

Diabexe Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled glucose levels, as discontinuation without medical supervision may lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, including dietary modifications, exercise, and weight management as advised by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before using Diabexe Duo if pregnant or breastfeeding. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glibmor M 2mg/500mg Tablet ER

There is no text provided to rephrase. Please provide the text you wish me to rewrite.

Uses of Glibmor M 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glibmor M 2mg/500mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glibmor M 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Glibmor M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glibmor M 2mg/500mg Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing. Glibmor M 2mg/500mg Extended-Release Tablets should be administered with a meal.

How Glibmor M 2mg/500mg Tablet ER works:

Glibmor M Extended-Release tablets (2mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glibmor M 2mg/500mg Extended-Release tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glibmor M 2mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible dangers prior to prescribing. Patient consultation with their doctor is recommended.

Breast feedingBreast feedingUNSAFE

Extended-release Glibmor M tablets (2mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glibmor M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. The use of Glibmor M 2mg/500mg Extended-Release tablets is contraindicated in patients experiencing severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glibmor M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, Glibmor M 2mg/500mg Extended-Release tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glibmor M 2mg/500mg Tablet ER :

Should you forget to take a Glibmor M 2mg/500mg Extended-Release tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glibmor M 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glibmor M 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glibmor M 2mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glibmor M 2mg/500mg Tablet ER and seek immediate medical attention.
Glibmor M 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glibmor M 2mg/500mg Tablet ER may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glibmor M 2mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Glibmor M 2mg/500mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glibmor M 2mg/500mg ER tablets and alcohol is unsafe. Alcohol can exacerbate the medication's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glibmor M 2mg/500mg Table...
62
MRP 75
17% off